State Ledger
Company profile

Climb Bio, Inc. CIK 1768446

Ticker
CLYM (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Wellesley Hills, MA
Fiscal year end
2025 (FY)
Market Data
Close
$10.82
Change
-$0.20
Change %
-1.77%
Volume
82,106

CLYM · trading date Oct 12, 2026 · previous close $11.02 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$59.85M
Total assets
$167.74M
Total liabilities
$7.27M
Stockholders' equity
$160.48M
Cash & equivalents
$35.69M
Operating income
-$67.88M
Operating cash flow
-$54.36M
Capital expenditures
$186.0K

Fiscal year 2025, via 10-K filed 2026-03-05. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$54.54M
Free cash flow margin
—
Liabilities / assets
4.3%
Equity / assets
95.7%
CapEx / revenue
—
Operating cash flow / net income
0.91×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$59.85M $167.74M $7.27M $160.48M
2024 — -$73.90M $217.19M $5.31M $211.88M
2023 — -$35.12M $110.47M $2.87M $107.60M
2022 — -$45.24M $134.99M $6.28M $128.72M
2021 — -$47.48M $173.24M $6.04M $167.20M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-05

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Wellesley Hills, MA
20 WILLIAM STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies